Cuiqiong Dai

Dr. Cuiqiong Dai


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2022 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
HYHuajing Yang
Huajing Yang
ZWZihui Wang
Zihui Wang
SXShan Xiao
Shan Xiao
CDCuiqiong Dai
Cuiqiong Dai
XWXiang Wen
Xiang Wen
PRPixin Ran
Pixin Ran
No statistically significant effect of serum uric acid on lung function was found in people without chronic obstructive pulmonary disease

1 August 2024 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
XWXiang Wen
Xiang Wen
XWXiaohui Wu
Xiaohui Wu
ZDZhishan Deng
Zhishan Deng
FWFan Wu
Fan Wu
HYHuajing Yang
Huajing Yang
YZYumin Zhou
Yumin Zhou
Background: The previous findings on the correlation between spirometry and high-density lipoprotein (HDL) cholesterol are intriguing yet conflicting. The aim of this research is to evaluate the relationship between HDL levels and spirometry as well as imaging parameters in patients with chronic obstructive pulmonary disease (COPD) in China. Methods: This study encompasses a total of 907 COPD patients. Participants with complete data from questionnaire interviews, lipid profile examinations, spirometry testing, and computed tomography (CT) scans were included in the analysis. A generalized additive model was employed to identify the non-linear relationship between HDL levels and both spirometry and imaging parameters. In the presence of non-linear correlations, segmented linear regression model was applied to ascertain threshold effects. Results: After adjusting for various factors, we found a non-linear correlation between HDL levels and spirometry/imaging parameters, with an inflection point at 4.2 (66 mg/dL). When Ln (HDL) was below 4.2, each unit increase correlated significantly with reduced post-bronchodilator FEV1 (0.32L, 95% CI: 0.09– 0.55), decreased predicted FEV1% (11.0%, 95% CI: 2.7– 19.3), and lowered FEV1/FVC (8.0%, 95% CI: 4.0– 12.0), along with notable increases in Ln (LAA− 950) by 1.20 (95% CI: 0.60– 1.79) and Ln (LAA− 856) by 0.77 (95% CI: 0.37– 1.17). However, no significant associations were observed when Ln (HDL) was greater than or equal to 4.2. Conclusion: A non-linear correlation existed between HDL levels with lung function and CT imaging in COPD patients. Prior to reaching 66 mg/dL, an elevation in HDL was significantly associated with impaired lung function, more severe gas trapping and emphysema.

1 March 2022 in Clinical Epidemiology
Verified
Journal Article
Open access
CDCuiqiong Dai
Cuiqiong Dai
ZWZihui Wang
Zihui Wang
HYHuajing Yang
Huajing Yang
SXShan Xiao
Shan Xiao
JXJianwu Xu
Jianwu Xu
PRPixin Ran
Pixin Ran
The potential protective role of serum total bilirubin (TB) for chronic obstructive pulmonary disease (COPD) is controversial. We aimed to investigate whether serum TB could prevent airflow limitation (reduce the risk of COPD) and whether these associations were causal or reversely causal. We conducted a multi-center and cross-sectional study including 3069 participants. Logistic regression model (LRM) with restricted cubic spline (RCS) and priori defined quintile categories were used to assess the associations of TB with COPD. Besides, ordinary least squares (OLS) regression model with RCS curves were applied to assess the dose-response relationship between serum TB and airflow limitation (FEV1/FVC). To verify the causal direction between TB and COPD, a bidirectional Mendelian randomization analysis was carried out with GWAS data from European ancestry. In the cross-sectional study, the relationship between levels of TB and COPD risk was U shaped (P=0.001), and the low and high concentrations of TB apparently increasing the risk of COPD (OR 1.40, 95% CI 1.07 to 1.82 for less than 9 μmol/L; OR 1.36, 95% CI 1.06 to 1.76 for 9.01–1 0.88 μmol/L; OR 1.50, 95% CI 1.16 to 1.95 for more than 13 μmol/L). There was a significant non-linear relationship between TB and FEV1/FVC (non-linear p=0.004). Furthermore, results of bidirectional Mendelian randomization analysis (OR 1.000; 95% CI 0.983 to 1.017 for MR and OR 0.998; 95% CI 0.976 to 1.020 for reversal MR) did not support the causal effects between serum TB and FEV1/FVC after controlling the effect of potential confounders and revised causality. Our study reveals that there was non-linear does-response pattern between serum TB and COPD. However, there was little evidence for the linear causal associations of serum TB with airflow limitation. The relationship of TB with COPD needs further study and careful interpretation.

1 May 2025 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
CDCuiqiong Dai
Cuiqiong Dai
GTGaoying Tang
Gaoying Tang
HYHuajing Yang
Huajing Yang
FWFan Wu
Fan Wu
ZDZhishan Deng
Zhishan Deng
PRPixin Ran
Pixin Ran
Background: Preserved ratio impaired spirometry (PRISm), which identifies a population at high risk for COPD, has drawn increasing attention. However, definitions for PRISm vary across studies, and researches comparing these definitions are limited. Objective: We aim to assess the agreement, the clinical features, and the prevalence of PRISm defined by restrictive spirometric pattern (RSP) method [that is forced vital capacity (FVC) method] versus forced expiratory volume in the first second (FEV1) method and by fixed values versus the lower limit of normal (LLN). Methods: All 1862 participants from the ECOPD study underwent questionnaire investigation, spirometry, biphasic CT, and impulse oscillometry. Participants were categorized into control and two targeted groups (RSP fixed and PRISm fixed excluding RSP fixed) based on FVC and FEV1 fixed definitions. Similar categorizations were conducted for RSP LLN versus PRISm LLN and PRISm fixed versus PRISm LLN. We assessed the agreement, the clinical features, and the prevalence of PRISm among these various definitions, repeating all analyses using Global Lung function Initiative (GLI) equation. Results: Significant overlap with merely moderate agreement (Kappa coefficient = 0.706, P value < 0.001) existed between RSP fixed and PRISm fixed definitions. Participants identified as PRISm by both definitions exhibited lower lung function, higher airway reactance, and increased airway resistance compared to the control group. Similar findings were observed in RSP LLN versus PRISm LLN and PRISm fixed versus PRISm LLN. Our sensitivity analysis verified the consistency of these results. Furthermore, the prevalence of PRISm varied from 2.0% to 12.5% depending on the definitions and predicted equations, with the Chinese equation, LLN definition in Chinese equation and fixed definition in GLI equation yielding higher prevalence rates. Conclusion: Our findings highlight concerns about the comparability of studies and the interchangeability of various definitions and reference equations for PRISm.

10 May 2025 in Chest
Verified
Journal Article
Open access
CDCuiqiong Dai
Cuiqiong Dai
FWFan Wu
Fan Wu
JTJia Tian
Jia Tian
JCJiangyu Cui
Jiangyu Cui
ZDZhishan Deng
Zhishan Deng
PRPixin Ran
Pixin Ran
PRISm is regarded as a COPD precursor, but whether this varies by smoking status remains unclear. Are annual lung function decline and the risk of developing airflow limitation different among PRISm subtypes by smoking status? 2850 participants from a 15-year population-based prospective cohort were included in this analysis. Participants were categorized into three groups: never smokers with normal spirometry (normal control), never smokers with PRISm (NS-PRISm), and ever smokers with PRISm (ES-PRISm). We compared the annual lung function decline and the risk of developing airflow limitation among the three groups. Participants in the normal control group exhibited the faster decline in annual lung function, followed by the ES-PRISm group, with the NS-PRISm group showing the slowest decline. Participants in the ES-PRISm group had a significant faster annual lung function decline than NS-PRISm group. Participants in the ES-PRISm group had a significantly increased risk of developing airflow limitation than NS-PRISm group (95/256 [37.1%] vs 69/470 [14.7%], adjusted HR: 1.90 [95%CI: 1.31 to 2.77], P=0.001) and normal control group (95/256 [37.1%] vs 193/2124 [9.1%], adjusted HR: 2.69 [95%CI: 1.96 to 3.69], P<0.001). Besides, participants in the NS-PRISm group also exhibited a higher risk of developing airflow limitation than those in the normal control group (69/470 [14.7%] vs 193/2124 [9.1%], adjusted HR: 1.41 [95%CI: 1.07 to 1.87], P=0.016). When the ES-PRISm group was further divided into current smokers with PRISm and former smokers with PRISm, both these PRISm subtypes showed a faster annual lung function decline and a similarly higher risk of airflow limitation compared to the NS-PRISm group. These findings suggest that both NS-PRISm and ES-PRISm may be potential precursors to COPD and indicate that PRISm should not be restricted to evaluating smokers alone.

1 November 2025 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
YLYuemao Li
Yuemao Li
JLJingwen Li
Jingwen Li
SHSuyin Huang
Suyin Huang
FWFan Wu
Fan Wu
ZDZhishan Deng
Zhishan Deng
PRPixin Ran
Pixin Ran
Purpose: This study aimed to evaluate the association between the forced expiratory volume in 3 s (FEV3) to forced vital capacity (FVC) and computed tomography (CT)-defined abnormalities, and to assess its potential value in predicting incident chronic obstructive pulmonary disease (COPD) over a 3-year period. Participants and Methods: This 3-year community-based cohort study enrolled participants with normal lung function (post-bronchodilator FEV1/FVC ≥ 0.70 and FEV1 ≥ 80% predicted). Baseline assessments included questionnaires, spirometry, CT scans, and impulse oscillometry. Participants were stratified by post-bronchodilator FEV3/FVC tertiles. Outcomes included acute respiratory events, annual lung function decline, and COPD incidence. Data were analyzed using mixed-effects models, log-binomial regression, and zero-inflated negative binomial models. Results: Of the 981 participants with normal baseline lung function stratified by post-bronchodilator FEV3/FVC tertiles (high: ≥ 95.5%, medium: 91.9– 95.4%, low: ≤ 91.8%), 807 completed the 3-year follow-up. Compared to the high-FEV3/FVC group, participants in the low-FEV3/FVC group tended to be older (60.5 vs 55.7 years) and included more males (80.4% vs 38.8%) and smokers. The low-FEV3/FVC group also demonstrated a lower baseline post-bronchodilator FEV1/FVC (74.0% vs 85.1%) and higher prevalence of emphysema (53.5% vs 18.3%). Longitudinal analysis revealed a greater annual post-bronchodilator FEV1 decline in the low-FEV3/FVC group (adjusted mean difference: 10 mL, 95% confidence interval [CI]: 0 to 21mL; p = 0.043) and an increased risk of developing COPD (19.4% versus 1.9%; adjusted relative risk: 4.96, 95% CI: 1.96– 12.51; p = 0.001) than the high-FEV3/FVC group, with no difference in acute respiratory events. Conclusion: A reduced FEV3/FVC ratio was associated with an increased risk of accelerated lung function decline and progression to COPD in individuals with normal spirometry. As a readily accessible measure derived from routine spirometry, FEV3/FVC may have a role in early COPD detection.